- Home
- DRUG vs PHT Comparison
DRUG vs PHT Comparison
Compare DRUG & PHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- PHT
- Stock Information
- Founded
- DRUG 2019
- PHT 2002
- Country
- DRUG United States
- PHT United States
- Employees
- DRUG N/A
- PHT N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- PHT Investment Managers
- Sector
- DRUG Health Care
- PHT Finance
- Exchange
- DRUG Nasdaq
- PHT Nasdaq
- Market Cap
- DRUG 233.2M
- PHT 231.2M
- IPO Year
- DRUG N/A
- PHT N/A
- Fundamental
- Price
- DRUG $33.19
- PHT $7.85
- Analyst Decision
- DRUG Strong Buy
- PHT
- Analyst Count
- DRUG 5
- PHT 0
- Target Price
- DRUG $83.25
- PHT N/A
- AVG Volume (30 Days)
- DRUG 25.6K
- PHT 85.5K
- Earning Date
- DRUG 05-20-2025
- PHT 01-01-0001
- Dividend Yield
- DRUG N/A
- PHT 8.76%
- EPS Growth
- DRUG N/A
- PHT N/A
- EPS
- DRUG N/A
- PHT 0.98
- Revenue
- DRUG N/A
- PHT N/A
- Revenue This Year
- DRUG N/A
- PHT N/A
- Revenue Next Year
- DRUG N/A
- PHT N/A
- P/E Ratio
- DRUG N/A
- PHT $7.71
- Revenue Growth
- DRUG N/A
- PHT N/A
- 52 Week Low
- DRUG $0.93
- PHT $6.41
- 52 Week High
- DRUG $79.02
- PHT $7.60
- Technical
- Relative Strength Index (RSI)
- DRUG 51.77
- PHT 67.42
- Support Level
- DRUG $29.59
- PHT $7.50
- Resistance Level
- DRUG $32.75
- PHT $7.65
- Average True Range (ATR)
- DRUG 1.99
- PHT 0.12
- MACD
- DRUG 0.14
- PHT 0.04
- Stochastic Oscillator
- DRUG 54.42
- PHT 91.30
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About PHT Pioneer High Income Fund Inc.
Pioneer High Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income and to seek capital appreciation by investing predominantly in below investment grade (high-yield) debt securities, loans, and preferred stocks.